Article
Ceramide synthase 6 (CerS6) promotes alcohol-induced fatty liver by promoting metabolic…
medRxiv · 2022 · Jeon, S.; Scorletti, E.; Buyco, D.; Lin, C.; Saiman, Y.; Martin, J.; Hooks, R.; Ogretmen, B.; Argemi, J.; Melo, L.; Bataller, R.; Carr, R. M.
Key facts
| Title | Ceramide synthase 6 (CerS6) promotes alcohol-induced fatty liver by promoting metabolic dysfunction and upregulating lipid droplet-associated proteins |
|---|---|
| First author | Jeon, S.; Scorletti, E.; Buyco, D.; Lin, C.; Saiman, Y.; Martin, J.; Hooks, R.; Ogretmen, B.; Argemi, J.; Melo, L.; Bataller, R.; Carr, R. M. |
| Journal | medRxiv |
| Published | Nov 4, 2022 |
| DOI | 10.1101/2022.11.03.514971 |
| Devices mentioned | BK110039, K040782 |
| Product codes mentioned | CEK, KIP, KIT, NJT, PFT, JAK, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1